Risk factors related to hypertension among patients in a cohort living with HIV/AIDS

dc.creatorArruda Junior, Evanizio Roque de
dc.creatorLacerda, Heloisa Ramos
dc.creatorMoura, Libia Cristina Rocha Vilela
dc.creatorAlbuquerque, Maria de Fatima Pessoa Militão de
dc.creatorMiranda Filho, Democrito de Barros
dc.creatorDiniz, George Tadeu Nunes
dc.creatorAlbuquerque, Valeria Maria Gonçalves de
dc.creatorAmaral, Josefina Cláudia Zirpoli
dc.creatorXimenes, Ricardo Alencar de Arraes
dc.creatorMonteiro, Verônica Soares
dc.date2018-08-30T12:17:55Z
dc.date2018-08-30T12:17:55Z
dc.date2010
dc.date.accessioned2023-09-26T22:38:49Z
dc.date.available2023-09-26T22:38:49Z
dc.identifierDE ARRUDA JUNIOR, E. R. et al. Risk factors related to hypertension among patients in a cohort living with HIV/AIDS. The Brazilian Journal of Infectious Diseases, v. 14, n. 3, p. 281–287, maio 2010.
dc.identifier1678-4391
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/28461
dc.identifier10.1016/S1413-8670(10)70057-X
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8881445
dc.descriptionINTRODUCTION: Studies disagree as to whether there is a greater prevalence of hypertension among HIV/AIDS patients and the role of antiretroviral therapy. OBJECTIVE: Evaluate the prevalence of hypertension and risk factors in a cohort of HIV-infected patients, with emphasis on antiretroviral therapy. METHOD: Case-control study conducted at baseline of a cohort, between June/2007 and December/2008 in Pernambuco/Brazil. Blood pressure was classified as normal, prehypertension, and hypertension. RESULTS: Of 958 patients, 245 (25.6%) had hypertension (cases), 325 (33.9%) had prehypertension, and 388 (40.5%) were normotensive (controls). Comparison between hypertensive and normotensive patients showed that traditional factors, such as age > 40 (OR = 3.06, CI = 1.91-4.97), male gender (OR = 1.85, CI = 1.15-3.01), BMI > 25 (OR = 5.51, CI = 3.36-9.17), and triglycerides > 150 mg/dL (OR = 1.69, CI = 1.05-2.71), were independently associated with hypertension. Duration of antiretroviral therapy and CD4 > 200 cells/mm³ were associated with hypertension in univariate analysis, but did not remain in final model. Type of antiretroviral schema and lipodystrophy showed no association with hypertension. CONCLUSION: Hypertension in HIV/AIDS patients is partially linked to invariable factors, such as age and sex. Efforts should be directed toward controlling reversible factors, particularly excessive weight gain and unsuitable diet.
dc.description2050-01-01
dc.formatapplication/pdf
dc.languageeng
dc.publisherElsevier
dc.rightsrestricted access
dc.subjectHIV / AIDS
dc.subjectHipertensão
dc.subjectTerapia anti-retroviral
dc.subjectRisco cardiovascular
dc.subjectHIV/AIDS
dc.subjectHypertension
dc.subjectAntiretroviral therapy
dc.subjectCardiovascular risk
dc.subjectAgentes Anti- HIV / uso terapêutico
dc.subjectTerapia Antirretroviral de Alta Atividade
dc.subjectBrasil / epidemiologia
dc.subjectContagem de linfócitos CD4
dc.subjectMétodos Epidemiológicos
dc.subjectFêmea
dc.subjectInfecções por HIV / complicações
dc.subjectInfecções por HIV / quimioterapia
dc.subjectInfecções por HIV / epidemiologia
dc.subjectHumanos
dc.subjectHipertensão / complicações
dc.subjectHipertensão / epidemiologia
dc.subjectEstilo de vida
dc.subjectCarga viral
dc.titleRisk factors related to hypertension among patients in a cohort living with HIV/AIDS
dc.typeArticle


Este ítem pertenece a la siguiente institución